Innovative & integrated solution providers in translational research to develop immunotherapies |
Toward Next Generation of Solution Providers
On September 30, 2019, 100 scientific professionals gathered in Paris for the 1st edition of a unique symposium to discuss ‘Innovative & Integrated Solution Providers in Translational Research to Develop Immunotherapies – Toward Next Generation of Solution Providers’.
Exploring the current trends in immunotherapies discovery & development from an academic, industrial & regulatory affairs point of view, the event was well received. Three expert speakers took to the stage to share research, findings & insights.
Egame
Take a few minutes to discover next generation partners to develop immunotherapies!
If you need to know more about us, contact Florence Fombertasse – Marketing & communication Manager - Oncodesign
INFOGRAPHICS
It is the first time ever that innovative solution providers gather to fill the gap of innovation in immunotherapies.
Download the infographics that illustrate our integrated offering can make you step ahead in market access.
Contact Florence Fombertasse – Marketing & communication Manager - Oncodesign.
Download our infographics
THE MEMBERS OF OUR NETWORK INNOVATIVE SOLUTION PROVIDERS
From Discovery to IND/CTA for innovative therapies thanks to precision medicine
Oncodesign is a biopharmaceutical company that fills in the innovation gaps in the healthcare industry, based on its unique precision medicine platform. Technological innovation lies at the heart of Oncodesign’s model—the Etiology, Discovery and Experimentation activities designed and implemented by Oncodesign contribute to a more effective approach to the phenomenon of innate and acquired resistance, more effective treatments and a reduction in therapeutic failures.
Exploratory Safety & PoC studies in translational non human primate models
Cynbiose aims to bring an innovative approach to the exploration of non human primate models by developing valuable translational models with a high scientific relevance for proof of concept (POC) studies, essential for initiating a successful clinical development.
Cynbiose manages this innovative approach by mastering all the steps and techniques required to fully utilize the potential of these complex preclinical models.
Advice & complete on a timely manner preclinical regulatory studies
ERBC (European Research Biology Center) is a European leader in non-clinical studies, offering to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity.
ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound.
Design & manage early clinical studies
Since its creation, Aepodia has confirmed its reputation by designing, preparing and conducting more than 90 Projects in healthy volunteers or patients with a strong focus on client’s needs and results outcomes. Aepodia experience has continuously grown and the company provides now a full services range covering all steps of a clinical trial. We have built a strong and worldwide reputation in the early clinical drug development sector.
Regulatory & pharmacovigilance
PharmaLex is one of the largest specialized providers of Development Consulting, Regulatory Affairs, Quality Management & compliance and Pharmacovigilance, Epidemiology & Risk Management worldwide. Our global teams of experts can take you through early strategic planning activities and non-clinical requirements to clinical development, through regulatory submission processes and finally guide you to market approval and product maintenance post-launch activities.